Sign In
Buy BGNE
$184.71
+0 (+0%)
At Close: Mar 28, 2025
Is a Surprise Coming for BeiGene (BGNE) This Earnings Season?
09:47am, Thursday, 23'rd Feb 2023
BeiGene (BGNE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Down -14.15% in 4 Weeks, Here's Why BeiGene, Ltd. (BGNE) Looks Ripe for a Turnaround
11:19am, Wednesday, 22'nd Feb 2023
BeiGene, Ltd. (BGNE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.
5 Best and Worst Performing Large-Cap Stocks in December 2022
10:51pm, Tuesday, 24'th Jan 2023
2022 was a difficult year for the equity market, with the S&P 500 down over 19%, its worst year since 2008 (down 38%).
5 Best and Worst Performing Health Care Stocks in December 2022
10:51pm, Monday, 23'rd Jan 2023
Despite inflation making it hard for the healthcare industry to manage its operating costs, there are a few positives that make this sector attractive to investors.
What Makes BeiGene, Ltd. (BGNE) a Good Fit for 'Trend Investing'
10:32am, Monday, 16'th Jan 2023
If you are looking for stocks that are well positioned to maintain their recent uptrend, BeiGene, Ltd. (BGNE) could be a great choice.
These Were the 5 Best and Worst Performing Large-Cap Stocks in Q4 2022
10:55pm, Friday, 06'th Jan 2023
The year 2022 proved to be the worst calendar year for the S&P 500 since 2008.
100 Best Stocks Of 2022: Oil Stocks And Medicals Shine
06:00pm, Friday, 30'th Dec 2022
Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business
Why Shares of BeiGene Were Up Wednesday
08:12am, Thursday, 01'st Dec 2022
The Chinese pharmaceutical stock is experiencing a comeback.
These Are the Five Best and Worst Performing Healthcare Stocks in October 2022
08:02pm, Monday, 28'th Nov 2022
The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.
Is This Chinese Pharmaceutical Stock Worth the Risk?
09:15am, Thursday, 03'rd Nov 2022
BeiGene's shares are down this year, but it has two potential blockbusters.
BeiGene, Ltd. (BGNE) Soars 20.6%: Is Further Upside Left in the Stock?
12:48pm, Thursday, 13'th Oct 2022
BeiGene, Ltd. (BGNE) saw its shares surge in the last session with trading volume being higher than average.
BeiGene Takes On Johnson & Johnson's Blockbuster Cancer Drug — And Wins
01:35pm, Wednesday, 12'th Oct 2022
BeiGene stock popped Wednesday after the company's leukemia treatment beat out a blockbuster drug from Johnson & Johnson. The post BeiGene Takes On Johnson & Johnson's Blockbuster Cancer Drug — And
4 Stocks With Solid Financial Strength
03:26pm, Tuesday, 04'th Oct 2022
Teradyne, BeiGene, Agnico Eagle Mines and On Holding have strong balance sheets. They seem strong enough to ward off bankruptcy risk in the short, medium and long term.
BeiGene: Best Biotech Industry Stock Bet Say Portfolio Wealth Builders
07:02am, Tuesday, 20'th Sep 2022
These articles are intended to provide readers with equity investment subjects [stocks, ETFs, REITs] which probably may experience rising market prices in next 3-5 months: Near-term expectations only.
7 Chinese Stocks to Sell While You Still Can
07:45am, Friday, 02'nd Sep 2022
Considering the slowdown in the world's second-largest economy, it's probably the right time to think about some Chinese stocks to sell. China barely escaped contraction during the second quarter as c
